Viroblock is a Geneva-based company founded in October 2005 with the goal of developing and commercializing a new generation of antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, such as human and avian influenzas, SARS virus and the AIDS virus. Given their particular antiviral mechanism, Viroblock’s products have a broad spectrum of action across virus families and do not lead to viral resistance.
Looking for a particular Viroblock SA employee's phone or email?
The Viroblock SA annual revenue was $405000 in 2026.
2 people are employed at Viroblock SA.
Viroblock SA is based in Plan-les-Ouates, Geneva.
The NAICS codes for Viroblock SA are [32, 3254, 32541, 325].
The SIC codes for Viroblock SA are [28, 283, 2834].